Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 05/09/2025 | CALL | $89.00 | 4,089 | +3,987 | +3,908.82% |
| 05/16/2025 | PUT | $77.00 | 1,168 | +1,003 | +607.88% |
| 05/02/2025 | PUT | $77.00 | 4,268 | +889 | +26.31% |
| 08/15/2025 | CALL | $85.00 | 2,848 | +846 | +42.26% |
| 06/20/2025 | CALL | $85.00 | 3,816 | +575 | +17.74% |
| 06/20/2025 | PUT | $80.00 | 4,698 | +510 | +12.18% |
| 06/20/2025 | CALL | $80.00 | 5,057 | -85 | -1.65% |
| 05/16/2025 | PUT | $79.00 | 661 | -105 | -13.71% |
| 05/16/2025 | PUT | $80.00 | 6,356 | -148 | -2.28% |
| 05/02/2025 | CALL | $83.00 | 3,626 | -176 | -4.63% |
| 05/02/2025 | CALL | $85.00 | 4,758 | -265 | -5.28% |
| 05/02/2025 | CALL | $88.00 | 11,242 | -716 | -5.99% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.04% | 77.07M | 8.28B |
| Vanguard 500 Index Fund | 2.31% | 58.61M | 6.3B |
| Fidelity 500 Index Fund | 1.09% | 27.79M | 2.99B |
| SPDR S&P 500 ETF Trust | 1.08% | 27.45M | 2.95B |
| iShares Core S&P 500 ETF | 0.89% | 22.63M | 2.43B |
| Vanguard Index-Value Index Fund | 0.86% | 21.91M | 2.35B |
| Select Sector SPDR Fund-Health Care | 0.81% | 20.59M | 2.21B |
| Vanguard Specialized-Health Care Fund | 0.72% | 18.31M | 1.97B |
| Vanguard Institutional Index Fund-Institutional Index Fund | 0.70% | 17.77M | 1.91B |
| Schwab Strategic Tr-Schwab U.S. Dividend Equity ETF | 0.68% | 17.38M | 1.87B |
Liver Cancer Treatment Market is expected to generate a revenue of USD 8.88 Billion by 2031, Globally, at 13.45% CAGR: Verified Market Research®
05/02 10:00 am
GlobeNewswire Inc.
Read moreThis Soaring Stock Just Delivered More Good News. Time to Buy?
05/02 08:30 am
The Motley Fool
Read moreShould Investors Buy Merck Stock After These Huge Risks?
04/30 11:30 am
The Motley Fool
Read moreAnalysis of Cancer Immunotherapy Technologies and Global Markets to 2029 - Merck, Roche, Bristol-Myers Squibb Company, Johnson & Johnson Services, and AstraZeneca Dominate
04/30 04:56 am
GlobeNewswire Inc.
Read moreWhy Is Summit Therapeutics Stock Trading Higher On Monday?
04/28 01:00 pm
Benzinga
Read moreMerck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion
04/28 12:17 pm
Benzinga
Read more80% of the EVX-01 vaccine targets trigger a tumor-reactive immune response - Evaxion presents striking EVX-01 data at the AACR Annual meeting
04/28 08:00 am
GlobeNewswire Inc.
Read more2 Outstanding Dividend Stocks to Buy and Hold For 20 Years
04/26 02:32 pm
The Motley Fool
Read moreWhat's Going On With Summit Therapeutics Stock On Friday?
04/25 03:14 pm
Benzinga
Read moreDurable Goods Orders Jump 9.2% In March, But One Category Tells The Real Story
04/24 09:20 am
Benzinga
Read moreGilead Cancer Drug Combined With Merck's Drug Effective In Difficult To Treat Type Of Breast Cancer
04/21 02:49 pm
Benzinga
Read moreMeningococcal Vaccines Market Size to Surpass $9.05 Billion, Globally, by 2032 at 10.4% CAGR: Coherent Market Insights
04/21 11:00 am
GlobeNewswire Inc.
Read moreהמועד האחרון לתביעה נגד MRK ביום שני: רוזן, מבכירי היועצים הגלובליים, מעודד את משקיעי Merck & Co., Inc. עם הפסדים של יותר מ-100 אלף דולר להבטיח ייעוץ לפני המועד האחרון החשוב של 14 באפריל בתביעה ייצוגית בניירות ערך – MRK
04/12 11:11 am
GlobeNewswire Inc.
Read moreMRK DEADLINE MONDAY: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Merck & Co., Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 14 Deadline in Securities Class Action – MRK
04/12 11:11 am
GlobeNewswire Inc.
Read moreWhy This Chinese Biotech Could Be Pharma's DeepSeek
04/11 10:18 am
Benzinga
Read moreAlarum Technologies Ltd. Investors: Please contact the Portnoy Law Firm to recover your losses. April 15, 2025 Deadline to file Lead Plaintiff Motion.
04/10 06:53 pm
GlobeNewswire Inc.
Read moreMerck & Co., Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. April 14, 2025 Deadline to file Lead Plaintiff Motion
04/10 06:46 pm
GlobeNewswire Inc.
Read moreBiopharmaceuticals Global Overview Report 2025: Global Market to Reach $698.7 Billion by 2030, Fueled by Specialized Therapies, Such as mAb and Gene Treatments, & a Strong Pipeline
04/10 05:59 am
GlobeNewswire Inc.
Read moreROSEN, GLOBAL INVESTOR COUNSEL, Encourages enCore Energy Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EU
04/09 05:36 pm
GlobeNewswire Inc.
Read moreShould You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
04/09 03:15 am
The Motley Fool
Read moreIs Vertex Pharmaceuticals Stock a Buy?
04/08 09:45 am
The Motley Fool
Read moreFaruqi & Faruqi Reminds Merck Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 - MRK
04/06 10:05 am
GlobeNewswire Inc.
Read moreMRK DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 14 Deadline in Securities Class Action – MRK
04/05 08:17 am
GlobeNewswire Inc.
Read moreBeiGene Discontinues Lung Cancer Drug Study After Interim Data Showed Limited Survival Benefit
04/03 11:19 am
Benzinga
Read moreDeadline Alert: Merck & Co (MRK) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
03/31 12:00 pm
GlobeNewswire Inc.
Read moreWhy Pfizer Is My Largest Healthcare Position
03/27 06:45 am
The Motley Fool
Read moreWhy Summit Therapeutics Stock Slipped Today
03/26 05:21 pm
The Motley Fool
Read moreDEADLINE ALERT for ICLR, ESTC, FMC, MRK: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions
03/26 12:00 pm
GlobeNewswire Inc.
Read moreWhy Pharma and Biotech Stocks Got Thrashed on Tuesday
03/25 06:47 pm
The Motley Fool
Read moreAnalyst Initiates Coverage On 'Undervalued' Summit Therapeutics
03/24 02:17 pm
Benzinga
Read morePharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed
03/21 12:31 pm
Benzinga
Read moreThe Gross Law Firm Reminds Merck Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 – MRK
03/20 01:01 pm
GlobeNewswire Inc.
Read moreDeadline Alert: Merck & Co (MRK) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
03/18 12:00 pm
GlobeNewswire Inc.
Read moreROSEN, LEADING INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK
03/16 05:57 am
GlobeNewswire Inc.
Read moreShould You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
03/16 05:20 am
The Motley Fool
Read moreDown 93%, Is It Finally Time to Buy Moderna?
03/15 04:38 am
The Motley Fool
Read moreROSEN, SKILLED INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK
03/13 06:59 pm
GlobeNewswire Inc.
Read moreBioengineered Protein Drugs Market Size to Cross USD 672.7 Billion by 2034, Growing at a CAGR of 6.2% - Report by Transparency Market Research, Inc.
03/13 06:00 pm
GlobeNewswire Inc.
Read moreThis Could Be the Catalyst That Sends Summit Therapeutics' Stock Higher This Year
03/13 07:30 am
The Motley Fool
Read moreMerck Plans Regulatory Submission For Two-Drug Regime For HIV Infection By Mid-2025
03/12 01:30 pm
Benzinga
Read moreROSEN, LEADING INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK
03/10 06:23 pm
GlobeNewswire Inc.
Read more3 Magnificent S&P 500 Dividend Stocks Down 20% to 63% to Buy and Hold Forever
03/09 04:35 am
The Motley Fool
Read moreIs This Beaten-Down Artificial Intelligence (AI) Stock a Buy?
03/08 11:02 am
The Motley Fool
Read more5 Top Stocks to Buy for March
03/08 10:54 am
The Motley Fool
Read more3 Safe-Haven Stocks to Buy Amidst a Global Trade War
03/05 10:35 am
Investing.com
Read moreROSEN, A LEADING NATIONAL FIRM, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK
03/04 08:57 pm
GlobeNewswire Inc.
Read more